VIX
80
-6
BBY
34
-7
DGX
47
3
EQIX
45
3
JNPR
58
2
PEP
51
-5
MKC
66
-2
FCX
39
5
DNB
40
2
EA
54
-5
CFG
40
10
GWW
41
-5
NI
70
3
JBHT
38
2
MSFT
48
2
HPE
10
4
ADM
28
-3
HSY
50
-6
EL
24
-4
EMR
54
3
VIX
80
-6
BBY
34
-7
DGX
47
3
EQIX
45
3
JNPR
58
2
PEP
51
-5
MKC
66
-2
FCX
39
5
DNB
40
2
EA
54
-5
CFG
40
10
GWW
41
-5
NI
70
3
JBHT
38
2
MSFT
48
2
HPE
10
4
ADM
28
-3
HSY
50
-6
EL
24
-4
EMR
54
3
Financhill
Back

Bel Fuse Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
43

BELFB
Bel Fuse

Last Price:
$77.03
Seasonality Move:
3.38%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$99.59
Seasonality Move:
6.73%
Sell
43
Bel Fuse (BELFB) is a Sell

Is Bel Fuse a Buy, Sell or Hold?

  • The current Bel Fuse [BELFB] share price is $76.80. The Score for BELFB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BELFB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BELFB Stock Price Chart

What is Bel Fuse's stock price today?

  • The Bel Fuse share price today is $76.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BELFB is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BELFB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -79735 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.25 - 83.47) Sell
Bollinger Bands (100): (77.73 - 84.15) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

BELFB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.1 Sell
20-day SMA: 81.66 Sell
50-day SMA: 81.18 Sell
200-day SMA: 74.73 Buy
8-day EMA: 79.5 Sell
20-day EMA: 80.83 Sell
50-day EMA: 81.08 Sell
200-day EMA: 75.05 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Bel Fuse Earnings Growth & BELFB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and an increase next year of $0.63 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Bel Fuse Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):